These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome. Berginc G; Bracko M; Ravnik-Glavac M; Glavac D Fam Cancer; 2009; 8(4):421-9. PubMed ID: 19526325 [TBL] [Abstract][Full Text] [Related]
25. Chemoprevention of hereditary colon cancers: time for new strategies. Ricciardiello L; Ahnen DJ; Lynch PM Nat Rev Gastroenterol Hepatol; 2016 Jun; 13(6):352-61. PubMed ID: 27095653 [TBL] [Abstract][Full Text] [Related]
26. Anticipating phenotypic differences from genetic mutations. You YN Dis Colon Rectum; 2015 Jan; 58(1):143-4. PubMed ID: 25489706 [No Abstract] [Full Text] [Related]
27. Current and future role of genetic screening in gynecologic malignancies. Ring KL; Garcia C; Thomas MH; Modesitt SC Am J Obstet Gynecol; 2017 Nov; 217(5):512-521. PubMed ID: 28411145 [TBL] [Abstract][Full Text] [Related]
28. Chemoprevention in hereditary colorectal cancer syndromes. Hawk E; Lubet R; Limburg P Cancer; 1999 Dec; 86(11 Suppl):2551-63. PubMed ID: 10630181 [TBL] [Abstract][Full Text] [Related]
29. Targeted therapy for hereditary cancer syndromes: hereditary breast and ovarian cancer syndrome, Lynch syndrome, familial adenomatous polyposis, and Li-Fraumeni syndrome. Agarwal R; Liebe S; Turski ML; Vidwans SJ; Janku F; Garrido-Laguna I; Munoz J; Schwab R; Rodon J; Kurzrock R; Subbiah V; Discov Med; 2014 Dec; 18(101):331-9. PubMed ID: 25549704 [TBL] [Abstract][Full Text] [Related]
30. In Lynch syndrome adenomas, loss of mismatch repair proteins is related to an enhanced lymphocytic response. Meijer TW; Hoogerbrugge N; Nagengast FM; Ligtenberg MJ; van Krieken JH Histopathology; 2009 Oct; 55(4):414-22. PubMed ID: 19817892 [TBL] [Abstract][Full Text] [Related]
31. Interobserver variability in the evaluation of mismatch repair protein immunostaining. Klarskov L; Ladelund S; Holck S; Roenlund K; Lindebjerg J; Elebro J; Halvarsson B; von Salomé J; Bernstein I; Nilbert M Hum Pathol; 2010 Oct; 41(10):1387-96. PubMed ID: 20573374 [TBL] [Abstract][Full Text] [Related]
32. Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy. Warrier SK; Trainer AH; Lynch AC; Mitchell C; Hiscock R; Sawyer S; Boussioutas A; Heriot AG Dis Colon Rectum; 2011 Dec; 54(12):1480-7. PubMed ID: 22067175 [TBL] [Abstract][Full Text] [Related]
33. Cohorts with familial disposition for colon cancers in chemoprevention trials. Burt RW J Cell Biochem Suppl; 1996; 25():131-5. PubMed ID: 9027609 [TBL] [Abstract][Full Text] [Related]
34. Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome. Guindalini RS; Win AK; Gulden C; Lindor NM; Newcomb PA; Haile RW; Raymond V; Stoffel E; Hall M; Llor X; Ukaegbu CI; Solomon I; Weitzel J; Kalady M; Blanco A; Terdiman J; Shuttlesworth GA; Lynch PM; Hampel H; Lynch HT; Jenkins MA; Olopade OI; Kupfer SS Gastroenterology; 2015 Nov; 149(6):1446-53. PubMed ID: 26248088 [TBL] [Abstract][Full Text] [Related]
37. Constitutional Mismatch Repair Deficiency in Israel: High Proportion of Founder Mutations in MMR Genes and Consanguinity. Baris HN; Barnes-Kedar I; Toledano H; Halpern M; Hershkovitz D; Lossos A; Lerer I; Peretz T; Kariv R; Cohen S; Half EE; Magal N; Drasinover V; Wimmer K; Goldberg Y; Bercovich D; Levi Z Pediatr Blood Cancer; 2016 Mar; 63(3):418-27. PubMed ID: 26544533 [TBL] [Abstract][Full Text] [Related]
38. [Recent advances and future development on Lynch syndrome-associated endometrial cancer]. Ning Y; Wang Y; Wang YY; Zheng WX Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):505-8. PubMed ID: 24246913 [No Abstract] [Full Text] [Related]
39. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study. Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419 [TBL] [Abstract][Full Text] [Related]
40. Updates in the field of hereditary nonpolyposis colorectal cancer. Peltomäki P; Olkinuora A; Nieminen TT Expert Rev Gastroenterol Hepatol; 2020 Aug; 14(8):707-720. PubMed ID: 32755332 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]